The Effects of Ex Vivo Administration of Granulocyte-Macrophage Colony-Stimulating Factor and Endotoxin on Cytokine Release of Whole Blood Are Determined by Priming Conditions
暂无分享,去创建一个
A. Nierhaus | S. Kluge | M. Winkler | J. Linssen | D. Frings
[1] J. Kellum,et al. Immune Cell Phenotype and Function in Sepsis , 2016, Shock.
[2] M. Netea,et al. Defective cytokine production early after multiple traumas: Modulation in severe sepsis. , 2015, Cytokine.
[3] WrightCraig Robert,et al. Regulation of Granulocyte Colony-Stimulating Factor and Its Receptor in Skeletal Muscle Is Dependent Upon the Type of Inflammatory Stimulus , 2015 .
[4] P. Pickkers,et al. Sepsis-induced immunoparalysis: mechanisms, markers, and treatment options. , 2015, Minerva anestesiologica.
[5] R. Hotchkiss,et al. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy , 2013, Nature Reviews Immunology.
[6] J. Hamilton,et al. Colony stimulating factors and myeloid cell biology in health and disease. , 2013, Trends in immunology.
[7] L. Koenderman,et al. Immunotherapy after trauma: timing is essential , 2011, Current opinion in anaesthesiology.
[8] J. Estaquier,et al. Cytokines modulate neutrophil death. , 2010, European cytokine network.
[9] T. Baumann,et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. , 2009, American journal of respiratory and critical care medicine.
[10] T. Baumann,et al. blind randomized placebo-controlled multicenter trial , 2009 .
[11] G. Franklin,et al. Systemic inflammation after trauma. , 2007, Injury.
[12] A. Ayala,et al. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock , 2007, Critical care medicine.
[13] M. Hino,et al. Selective activation of STAT3 in human monocytes stimulated by G-CSF: implication in inhibition of LPS-induced TNF-alpha production. , 2004, American journal of physiology. Cell physiology.
[14] T. Hartung,et al. Perioperative Recombinant Human Granulocyte Colony-Stimulating Factor (Filgrastim) Treatment Prevents Immunoinflammatory Dysfunction Associated With Major Surgery , 2004, Annals of surgery.
[15] S. Lendemans,et al. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma , 2003, Critical care medicine.
[16] G. Otto,et al. GM-CSF Restores Innate, But Not Adaptive, Immune Responses in Glucocorticoid-Immunosuppressed Human Blood In Vitro1 , 2003, The Journal of Immunology.
[17] A. Nierhaus,et al. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis , 2003, Intensive Care Medicine.
[18] P. Newburger,et al. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. , 2002, Blood.
[19] John W. Wilson,et al. A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. , 2002, American journal of respiratory and critical care medicine.
[20] J. Marshall,et al. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence , 2002, Critical care.
[21] O. Derman,et al. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. , 2001, Pediatrics.
[22] T. Hartung,et al. Blood cytokine response of low-dose molgramostim (rhGM-CSF)-treated patients. , 2000, Cytokine.
[23] J. Klein,et al. Granulocyte-Macrophage Colony-Stimulating Factor Delays Neutrophil Constitutive Apoptosis Through Phosphoinositide 3-Kinase and Extracellular Signal-Regulated Kinase Pathways1 , 2000, The Journal of Immunology.
[24] H. Volk,et al. Clinical aspects: from systemic inflammation to 'immunoparalysis'. , 2000, Chemical immunology.
[25] E. Kreuzfelder,et al. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. , 1999, Annals of surgery.
[26] M. Williams,et al. Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo. , 1998, The Journal of infectious diseases.
[27] J. Cavaillon,et al. Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome. , 1998, Blood.
[28] N. Petrelli,et al. Randomized, placebo-controlled, multicenter trial of granulocyte-macrophage colony-stimulating factor as infection prophylaxis in oncologic surgery. Leukine Surgical Prophylaxis Research Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] M. Williams,et al. Granulocyte-macrophage colony-stimulating factor induces activation and restores respiratory burst activity in monocytes from septic patients. , 1998, The Journal of infectious diseases.
[30] F. Schade,et al. Regulation of whole blood tumor necrosis factor production upon endotoxin stimulation after severe blunt trauma. , 1997, The Journal of trauma.
[31] T. Hartung,et al. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. , 1997, Blood.
[32] T. van der Poll,et al. Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin. , 1996, The Journal of infectious diseases.
[33] R. Bone,et al. Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.
[34] L. V. Van Pelt,et al. A single dose of granulocyte-macrophage colony-stimulating factor induces systemic interleukin-8 release and neutrophil activation in healthy volunteers. , 1996, Blood.
[35] K. Asadullah,et al. Very low monocytic HLA-DR expression indicates high risk of infection--immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy. , 1995, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.
[36] Marc A. Williams,et al. Administration of rHuGM‐CSF activates monocyte reactive oxygen species secretion and adhesion molecule expression in vivo in patients following high‐dose chemotherapy , 1995, British journal of haematology.
[37] F. Schildberg,et al. Downregulation of proinflammatory cytokine release in whole blood from septic patients. , 1995, Blood.
[38] W. Hiddemann,et al. Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins , 1992, Antimicrobial Agents and Chemotherapy.
[39] J. Cavaillon,et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. , 1991, The Journal of clinical investigation.
[40] H. Polk,et al. HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. , 1991, American journal of surgery.
[41] H. Polk,et al. Monocyte HLA‐DR antigen expression characterizes clinical outcome in the trauma patient , 1990, The British journal of surgery.
[42] D. Metcalf. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. , 1986, Blood.